Subscribe to the newsletterForward | Contact | www.lyonbiopole.com   April 2013
 
A LA UNE
04/30/2013 - BIO Chicago 2013: Very successful event for Lyonbiopole and its 19 member companies, of the Rhone-Alpes Region

Lyonbiopole has participated in “BIO International Convention” with 19 member companies on 22nd to 25th April, 2013 in Chicago. BIO is the most important life sciences international exhibition. At the opening of BIO, on Monday 22th April, was held the 7th edition of the "Fast-Track R&D Partnering with France". This international collective action of the 7 health/biotech French clusters, is led by Lyonbiopole, in partnership with UbiFrance and with the support of the DGCIS of the French Ministry of Industrial Renewal. This initiative gathered more than 200 attendees participated in the meeting, half international and half French.
Contact: Isabelle Scarabin, Economic and International Affairs Director - isabelle.scarabin@lyonbiopole.com / Kevin Romani, International Project Manager - kevin.romani@lyonbiopole.com

Learn more


10/11/2013 - Partnering Days, save-the-date !

The 7th edition of the Partnering Days will take place on October Friday 11th 2013 at the "Espace de l'Ouest Lyonnais" in Lyon.
Contact : Claudia Chagneau, Chargée de projets R&D - claudia.chagneau@lyonbiopole.com

Learn more


03/29 to 04/29/2013 - "Lyonbiopole in action": listen to the last three interviews

This month on Lyon 1ère: Kevin Romani and Emilie Roméo, Project Manager at Lyonbiopole ; Karin Hollerbach, Executive Director of Taku group and American expert specialized in SMBs'economic development and growth in the field of biotechnology ; Stéphane Legastelois, CEO, Indicia Biotechnology.
Contact: Périne Michon, Communication assistant - perine.michon@lyonbiopole.com

Learn more



ZOOM SUR
Axo Science

AXO Science is specialized in the development of high-throughput and multiplexed microarray diagnostic solutions dedicated to the characterization of biological samples. AXO Science develops and commercializes fully robotized diagnostic solutions and is involved in numerous research projects dedicated to medical diagnostic (lever cancer, bladder cancer, allergies etc.). These solutions aim at answering new medical challenges we are facing by enabling early diagnosis and large-scale tests that are today unrealistic both for technical and financial reasons.AXO Science aims at setting the Gold Standard in high-throughput microarray technologies.

Learn more



A LA UNE
04/09/2013 - The 7th "Investors Meetings" dedicated to Rhone-Alpes Creation

Lyonbiopole continues its support to the economic development of its members by organizing, throughout the year, investors meetings which take place in two stages: during the day, individual meetings between member companies and private investor and during lunch a workshop followed by a networking buffet to facilitate exchanges. On April 9th, 12 Lyonbiopole SMBs members met Rhone-Alpes Creation. In 2012, Rhone-Alpes Creation has completed 13 transactions, including 9 refinancing and 4 new investments in just five months of activity representing a total commitment of € 1.3M.
Contact: Kevin Romani, International Project Manager - kevin.romani@lyonbiopole.com

Learn more


05/23/2013 - Lyonbiopole partner of the 16th edition of the Forum 4i®. This year, the Venture Capital Forum becomes Venture4i

The 16th edition of Forum 4i® (Innovation, Industry, Investment, International) organized by the City of Grenoble will take place on May 23rd, 2013  at the Worlds Trade Center Congress Center, on the following topic: «smart mobility, use and innovations ». Novelty 2013, the Venture Capital Forum evolves and changes in size to become the Venture4i. The objective is to organize meetings between innovative companies and investors. Four industrial leaders will present their open innovation and partnership strategy: Bosch Group, 3M, Sony Corporation, SEB Group.
Contact: Kevin Romani, International Project Manager - kevin.romani@lyonbiopole.com

Learn more


06/03 to 06/07/2013 - "Oncology and Immunology" collective trade mission on the East Coast of the United States

Lyonbiopole invites its members to participate to the "Oncology and Immunology" collective trade mission which will take place on June 3rd to 7th, 2013 on the East Coast of the United States in Boston. This mission is the result of a partnership between all French health competitiveness clusters. It is organized by UbiFrance and supported by DGCIS.
Contact : Kevin Romani, International Project Manager - kevin.romani@lyonbiopole.com

Learn more


07/02/2013 - Accinov starts an innovation network dedicated to biomanufacturing technology and equipment

As part of the program BioMaTools, Accinov sets-up a multidisciplinary innovation network dedicated to the development of novel technology and tools for biomanufacturing. A kick-off meeting will be organized on Thursday, July 2nd in Lyon.
Contact: Sylvain Peyrache, BioMaTools program manager - sylvain.peyrache@accinov.com.

Learn more



AGENDA
Forum 4i® and Venture4i,
May 22nd to 23rd, 2013, Grenoble - France
15th édition of BIOFORUM-BIOTECH
May, 29th to 31st, 2013, Shanghai - China
5th Berlin-Brandenburg Technology Forum "In vitro-Diagnostics and Bioanalysis",
June 5th to 6th, 2013, Berlin - Germany
ILSI Biomed Israel,
June 10th to 12th, 2013, Tel Aviv - Israël
Creating New Business Opportunities for SMEs in the Life Sciences Area: Are you already prepared for H2020 in the Health sector ?
June 13th, 2013, Brussels - Belgium
BioPurification,
Le 18 juin 2013, Lyon - France
23rd ESACT Meeting : Better Cells for Better Health
June 23rd to 26th, 2013, Lille - France
BioPartnering Latin AmericaTM,
September 10th to 12th, 2013, Rio de Janeiro - Brazil
5th European Congress of Virology 2013,
September 11th to 14th, 2013, Lyon - France
BioPharm AmericaTM 2013,
September 17th to 19th, 2013, Boston - United States
ILMAC - Internationale Messe für Pharma Chemie Biotechnologie : Competence in Process and Laboratory Technology
September 24th to 27th, 2013, Messe Basle - Switzerland
Euromediag International Convention (EIC) 2013,
September 25th to 26th, 2013, Montpellier - France
BioJapan 2013,
October 9th to 11th, Yokohama - Japan
Convention ECCP 2013,
October 14th to 15th, 2013, Toulouse - France
BIO-Europe 2013,
November 4th to 6th, 2013, Vienna - Austria
Genesis 2013,
December 12th, 2013,  London - United Kingdom
 
A LA UNE
03/11/2013 - Focus on LabCom call for projects of the National Research Agency

A labCom "Public research organizations - SMBs / MSE common laboratories " call for projects was launched by the ANR to encourage public research actors to create new structured partnerships through the creation of " joint laboratories" between SMB or Medium Sized Enterprises and laboratory of public research organization. The deadline for applications  submission to the ANR is May 31st, 2013 at 1:00 pm. Note: in this context, the "cluster" label is considered by the steering committees in the project selection process. The application for accreditation by Lyonbiopole must be completed no later than one month before the deadline of the ANR selected call for project.
Contact: Claudia Chagneau, R&D Projects Manager – claudia.chagneau@lyonbiopole.com

Learn more


04/01/2013 - 5th MATWIN call for application in oncology

This call is open to academic researchers and clinicians concerned by oncology innovation which has reached the patenting stage. Research teams will find in the MATWIN program means to increase the attractiveness of their projects for the major players in oncology. To answer this call, project leaders must initially fill a letter of intent no later than May 15th, 2013.
Contact: Cécile Faurie, MATWIN project Manager, cecile.faurie@matwin.org

Learn more


3/2013 - Open FP7-PEOPLE Program (researchers mobility program call for project)

IEF (Intra-European Fellowships), IOF (International Outgoing Fellowships) and IIF (International Incoming Fellowships) calls for projects were published on March 14th, 2013. Their respectively budget being of € 134M, € 44,5M and € 44,5M, these calls will be closed on August 14th, 2013 at 5:00 pm. The PEOPLE program finances transnational mobility of researchers in academic laboratories and within companies. We remind you that under its PPTE program, Lyonbiopole assists you in setting up your European projects.
Contact: Emilie Romeo, Project manager -  emilie.romeo@lyonbiopole.com

Learn more



A LA UNE
03/04/2013 - A new President at Aguettant's head

Eric Rougemond has been appointed Chief Executive Officer (CEO) of Laboratoire Aguettant. He takes the succesion of Michel Fasné at the head of the laboratory.

Learn more


03/19/2013 - ETHERA makes a € 3M second fundraising

ETHERA, start-up developing innovative diagnostic solutions and disposal indoor air chemical pollution, announced the closing of its second fundraising for a total of €3 million. These funds, raised from EMERTEC, initial investor, NEC-K and SEB ALLIANCE, allow the large-scale production of materials and the development of the company on the international and the general public markets.

Learn more


03/22/2013 - Bio-Modeling Systems and Persistent Systems launch joint strategic Systems Biology initiative

Bio-Modeling Systems (BMSystems), a leading integrative systems biology company and, Persistent Systems, the global leader in software product and technology services, announced a joint systems biology research and development initiative. The strategic initiative is the world’s first collaborative effort that marries non-mathematical heuristic modeling with mathematical modeling designed to increase the success rates of drug discovery and formulation development by pharmaceutical and cosmetic industries.

Learn more


03/25/2013 - Sanofi and Transgene announce innovative long-term collaboration for the manufacturing of immunotherapy treatments

Sanofi and Transgene signed a collaboration agreement for the creation of a new high-tech industrial platform dedicated to the manufacturing of immunotherapy products including Transgene’s therapeutic products. The platform will be set-up on Genzyme Polyclonals site in Lyon - Gerland area for an investment amount of € 10M equally financed by Sanofi and Transgene. The Platform will remain Sanofi’s exclusive property.

Learn more


04/03/2013 - ERYTECH Pharma receives FDA IND clearance to initiate a clinical study, on Acute Lymphoblastic Leukemia, in the U.S

ERYTECH Pharma SA announced today that it has received clearance of its Investigational New Drug (IND) Application from the United States Food and Drug Administration (FDA) to initiate a Phase I clinical trial of its product ERYASP®, L-asparaginase loaded erythrocytes, in patients 40 years or older with newly diagnosed Acute Lymphoblastic Leukemia (ALL). ERYTECH, French biopharmaceutical company that designs innovative treatments for acute leukaemia and other oncology indications with unmet medical needs, announces that the French market regulator Autorité des Marchés Financiers (AMF) granted its visa n°13-166 on April 17, 2013 for the prospectus relative to the listing of ERYTECH shares on the NYSE Euronext regulated market in Paris.

Learn more


04/16/2013 - EVEON and Alaxia, Lyonbiopole's members, sign a major industrial partnership

EVEON, designer and manufacturer of medical devices for the preparation and/or administration of complex drugs, has signed a major industrial partnership with the Alaxia company. This partnership is established for the development of a home-manufacturing device for ALX-009, a new treatment against Cystic Fibrosis.

Learn more

 
© Lyonbiopole 2019  |  CREDITS  |  LEGAL NOTICE  |